BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32969796)

  • 1. Challenges in early diagnosis of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma: a case series of four patients.
    Onsun N; Dizman D; Emiroğlu N; Yildiz P; Akaslan TÇ; Tosuner Z; Çetin G; Demirkesen C
    Eur J Dermatol; 2020 Aug; 30(4):358-361. PubMed ID: 32969796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls in diagnosing primary cutaneous aggressive epidermotropic CD8
    Deenen NJ; Koens L; Jaspars EH; Vermeer MH; Willemze R; de Rie MA; Bekkenk MW
    Br J Dermatol; 2019 Feb; 180(2):411-412. PubMed ID: 30259963
    [No Abstract]   [Full Text] [Related]  

  • 3. [Facial ulcerated nodules revealing primary cutaneous CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma].
    Rolland M; Dinulescu M; Saillard C; Battistella M; Le Gall F; Lhomme F; Gangneux JP; Dupuy A; Adamski H
    Ann Dermatol Venereol; 2020 Nov; 147(11):764-768. PubMed ID: 32527516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar Primary Cutaneous CD8+ Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma.
    Morse DC; Park KE; Chitsazzadeh V; Li S; Young K; Gunther JR; Dabaja BS; Duvic M
    Int J Gynecol Pathol; 2021 May; 40(3):229-233. PubMed ID: 33741766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
    Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
    Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
    Gomez Vazquez M; Navarra Amayuelas R
    Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
    Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
    J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation.
    Nofal A; Abdel-Mawla MY; Assaf M; Salah E
    J Am Acad Dermatol; 2012 Oct; 67(4):748-59. PubMed ID: 22226429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.
    Lee J; Yang YJ; Kim JI; Park JH; Kim WS
    Indian J Ophthalmol; 2015 Jan; 63(1):81-2. PubMed ID: 25686076
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cutaneous CD8+ epidermotropic cytotoxic T-cell lymphoma with aggressive course].
    Poszepczynska-Guigné E; Jagou M; Wechsler J; Dieng MT; Revuz J; Bagot M
    Ann Dermatol Venereol; 2006 Mar; 133(3):253-6. PubMed ID: 16800177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
    Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid deterioration in a patient with primary aggressive cutaneous epidermotropic CD8+ cytotoxic T-cell ('Berti') lymphoma after administration of adalimumab.
    Jacks SM; Taylor BR; Rogers RP; Ralston JS; Metcalf JS; Lazarchick J
    J Am Acad Dermatol; 2014 Sep; 71(3):e86-7. PubMed ID: 25128139
    [No Abstract]   [Full Text] [Related]  

  • 13. [Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma].
    Gardette E; Moguelet P; Barete S; Frances C; Senet P
    Ann Dermatol Venereol; 2016 Dec; 143(12):846-851. PubMed ID: 27161647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphomatoid papulosis type D or an aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma?
    Andersen RM; Larsen MS; Poulsen TS; Lauritzen AF; Skov L
    Acta Derm Venereol; 2014 Jul; 94(4):474-5. PubMed ID: 24217891
    [No Abstract]   [Full Text] [Related]  

  • 15. Rare provisional entity: primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma in a young woman.
    Csomor J; Bognár A; Benedek S; Sinkó J; Fekete S; Krenács L; Matolcsy A; Reiniger L
    J Clin Pathol; 2008 Jun; 61(6):770-2. PubMed ID: 18505891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4/CD8 double-negative T-cell lymphoma: a variant of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma?
    Miyauchi T; Abe R; Morita Y; Adachi M; Shiba K; Hamade Y; Saito N; Nishimura M; Ibata M; Okada K; Shigematsu A; Endo T; Kawai K; Teshima T; Shimizu H
    Acta Derm Venereol; 2015 Nov; 95(8):1024-5. PubMed ID: 25792011
    [No Abstract]   [Full Text] [Related]  

  • 17. Febrile ulceronecrotic Mucha Habermann disease mimicking aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma: a diagnostic challenge.
    Lalevee S; Ortonne N; Hotz C; Schlemmer F; Beldi-Ferchiou A; Delfau-Larue MH; Wolkenstein P; Chosidow O; Ingen-Housz-Oro S
    Eur J Dermatol; 2018 Dec; 28(6):834-835. PubMed ID: 30325315
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Cutaneous CD8+ T-cell Lymphoma, an Indolent and Locally Aggressive Form Mimicking Paronychia.
    Beggs SM; Friedman BJ; Kornreich D; Okon L; Alpdogan O; Shi W; Sahu J
    Am J Dermatopathol; 2018 Apr; 40(4):e52-e56. PubMed ID: 28984695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
    Wang L; Gao T; Wang G
    J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
    Kasuya A; Hirakawa S; Tokura Y
    Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.